Literature DB >> 33678410

A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project.

Larry M Baddour1, Aylin Shafiyi2, Brian D Lahr3, Nandan S Anavekar4, James M Steckelberg2, Walter R Wilson2, M Rizwan Sohail5, Daniel C DeSimone5.   

Abstract

OBJECTIVE: To develop a contemporary profile of infective endocarditis (IE) among a population in 6 counties of Olmsted, Dodge, Mower, Steele, Waseca, and Freeborn in southern Minnesota between 2014 and 2018. PATIENTS AND METHODS: All possible and definite cases of IE (≥18 years) among residents of 6 counties in southern Minnesota, including Olmsted County, diagnosed between January 1, 2014, and December 31, 2018, were included in this retrospective, population-based investigation, using the Expanded Rochester Epidemiology Project (E-REP).
RESULTS: Overall, 137 patients with IE developed incident IE in the 6-county region, corresponding to an age- and sex-adjusted incidence rate of 11.9 per 100,000 person-years. Men had a significantly higher incidence of IE (17.9 vs 6.8 per 100,000 person-years), and rates increased exponentially with age in both sexes. The median age of incident cases was 68.2 years, and 67.9% were male patients. The percentage of patients with histories of injection-drug use was low, at 6.7%. Bicuspid aortic valve was the most common (9.6%) native valve predisposing condition. Staphylococcus aureus was identified as the predominant pathogen in the overall group (34.8%), with viridans-group streptococci accounting for only 19.3% cases. Central nervous system and musculoskeletal complications were common. The 30-day readmission rate was 27.9%, and the 6-month mortality rate was 31.8%.
CONCLUSION: To our knowledge, this is the first time that the population-based E-REP has been used to determine an age- and sex-adjusted IE incidence. Older male patients predominated, and S aureus was the most common pathogen. Based on these findings, it is not surprising that IE complications were frequently seen.
Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33678410      PMCID: PMC8180504          DOI: 10.1016/j.mayocp.2020.08.044

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   11.104


  22 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  An alarming rise in incidence of infective endocarditis in England since 2009: why?

Authors:  Martin H Thornhill; Mark J Dayer; Jon Nicholl; Bernard D Prendergast; Peter B Lockhart; Larry M Baddour
Journal:  Lancet       Date:  2020-04-25       Impact factor: 79.321

4.  Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands.

Authors:  Floris S van den Brink; Martin J Swaans; Mark G Hoogendijk; Arash Alipour; Johannes C Kelder; Wybren Jaarsma; Frank D Eefting; Bjorn Groenmeijer; A Jon Funke Kupper; Jurrien M Ten Berg
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-04-01

5.  Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota.

Authors:  Imad M Tleyjeh; James M Steckelberg; Hani S Murad; Nandan S Anavekar; Hassan M K Ghomrawi; Zaur Mirzoyev; Sherif E Moustafa; Tanya L Hoskin; Jayawant N Mandrekar; Walter R Wilson; Larry M Baddour
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis.

Authors:  Mark J Dayer; Simon Jones; Bernard Prendergast; Larry M Baddour; Peter B Lockhart; Martin H Thornhill
Journal:  Lancet       Date:  2014-11-18       Impact factor: 79.321

7.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

Review 8.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

9.  Thirty-Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database.

Authors:  Yusuke Morita; Tetsuya Haruna; Yoshisumi Haruna; Eisaku Nakane; Yuhei Yamaji; Hideyuki Hayashi; Michiya Hanyu; Moriaki Inoko
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

10.  Infective endocarditis in the U.S., 1998-2009: a nationwide study.

Authors:  David H Bor; Steffie Woolhandler; Rachel Nardin; John Brusch; David U Himmelstein
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more
  2 in total

1.  Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study.

Authors:  Ruchi Bhandari; Shabnam Tiwari; Talia Alexander; Frank H Annie; Umar Kaleem; Affan Irfan; Sudarshan Balla; R Constance Wiener; Chris Cook; Aravinda Nanjundappa; Mark Bates; Ellen Thompson; Gordon S Smith; Judith Feinberg; Melanie A Fisher
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

Review 2.  Infective Endocarditis in High-Income Countries.

Authors:  Francesco Nappi; Giorgia Martuscelli; Francesca Bellomo; Sanjeet Singh Avtaar Singh; Marc R Moon
Journal:  Metabolites       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.